Literature DB >> 7761416

Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion.

T Hackstadt1, M A Scidmore, D D Rockey.   

Abstract

Chlamydia trachomatis undergoes its entire life cycle within an uncharacterized intracellular vesicle that does not fuse with lysosomes. We used a fluorescent Golgi-specific probe, (N-[7-(4-nitrobenzo-2-oxa-1,3-diazole)]) aminocaproylsphingosine (C6-NBD-Cer), in conjunction with conventional fluorescence or confocal microscopy to identify interactions between the Golgi apparatus and the chlamydial inclusion. We observed not only a close physical association between the Golgi apparatus and the chlamydial inclusion but the eventual presence of a metabolite of this fluorescent probe associated with the chlamydiae themselves. Sphingomyelin, endogenously synthesized from C6-NBD-Cer, was specifically transported to the inclusion and incorporated into the cell wall of the intracellular chlamydiae. Incorporation of the fluorescent sphingolipid by chlamydiae was inhibited by brefeldin A. Chlamydiae therefore occupy a vesicle distal to the Golgi apparatus that receives anterograde vesicular traffic from the Golgi normally bound for the plasma membrane. Collectively, the data suggest that the chlamydial inclusion may represent a unique compartment within the trans-Golgi network.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7761416      PMCID: PMC41810          DOI: 10.1073/pnas.92.11.4877

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  The titration of trachoma and inclusion blennorrhoea viruses in cell cultures.

Authors:  G FURNESS; D M GRAHAM; P REEVE
Journal:  J Gen Microbiol       Date:  1960-12

Review 3.  The interaction of bacteria with mammalian cells.

Authors:  S Falkow; R R Isberg; D A Portnoy
Journal:  Annu Rev Cell Biol       Date:  1992

Review 4.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

5.  Mechanism of C. trachomatis attachment to eukaryotic host cells.

Authors:  J P Zhang; R S Stephens
Journal:  Cell       Date:  1992-05-29       Impact factor: 41.582

Review 6.  Lipid traffic in eukaryotic cells: mechanisms for intracellular transport and organelle-specific enrichment of lipids.

Authors:  R E Pagano
Journal:  Curr Opin Cell Biol       Date:  1990-08       Impact factor: 8.382

7.  Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus.

Authors:  A H Futerman; B Stieger; A L Hubbard; R E Pagano
Journal:  J Biol Chem       Date:  1990-05-25       Impact factor: 5.157

8.  In situ studies on incorporation of nucleic acid precursors into Chlamydia trachomatis DNA.

Authors:  G McClarty; G Tipples
Journal:  J Bacteriol       Date:  1991-08       Impact factor: 3.490

9.  Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells.

Authors:  D D Rockey; R A Heinzen; T Hackstadt
Journal:  Mol Microbiol       Date:  1995-02       Impact factor: 3.501

Review 10.  Brefeldin A: insights into the control of membrane traffic and organelle structure.

Authors:  R D Klausner; J G Donaldson; J Lippincott-Schwartz
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

View more
  164 in total

1.  Chlamydial antigens colocalize within IncA-laden fibers extending from the inclusion membrane into the host cytosol.

Authors:  W J Brown; Y A W Skeiky; P Probst; D D Rockey
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

2.  Localization and characterization of GTP-binding protein CT703 in the Chlamydia trachomatis-Infected cells.

Authors:  Kun Du; Fuyan Wang; Zhi Huo; Jie Wang; Wen Cheng; Ming Li; Ping Yu
Journal:  Curr Microbiol       Date:  2010-08-20       Impact factor: 2.188

3.  Resistance to a novel antichlamydial compound is mediated through mutations in Chlamydia trachomatis secY.

Authors:  Kelsi M Sandoz; Steven G Eriksen; Brendan M Jeffrey; Robert J Suchland; Timothy E Putman; Dennis E Hruby; Robert Jordan; Daniel D Rockey
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

4.  Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells.

Authors:  Meghan Zuck; Caroline Feng; Kevin Hybiske
Journal:  J Vis Exp       Date:  2015-10-13       Impact factor: 1.355

5.  Chlamydia pneumoniae infected macrophages exhibit enhanced plasma membrane fluidity and show increased adherence to endothelial cells.

Authors:  Anthony A Azenabor; Godwin Job; Olanrewaju O Adedokun
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

Review 6.  Role of sphingolipids in microbial pathogenesis.

Authors:  Lena J Heung; Chiara Luberto; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 7.  Acquisition of nutrients by Chlamydiae: unique challenges of living in an intracellular compartment.

Authors:  Hector Alex Saka; Raphael H Valdivia
Journal:  Curr Opin Microbiol       Date:  2009-12-16       Impact factor: 7.934

8.  Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis.

Authors:  Gabrielle Keb; Kenneth A Fields
Journal:  J Vis Exp       Date:  2020-01-30       Impact factor: 1.355

Review 9.  Mechanisms and functional features of polarized membrane traffic in epithelial and hepatic cells.

Authors:  M M Zegers; D Hoekstra
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

10.  Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates.

Authors:  J P Bannantine; W E Stamm; R J Suchland; D D Rockey
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.